LUND, SE / ACCESSWIRE / May 21, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its interim report for the first quarter of 2024.
"The year has started very well for Cantargia and our clinical project, CAN10, has come into the spotlight. CAN10 has great potential for the treatment of various inflammatory diseases, and new results from our own and competitors' studies reinforce this view. Additionally, our other... (continue reading...)
LUND, SE / ACCESSWIRE / May 21, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its interim report for the first quarter of 2024.
"The year has started very well for Cantargia and our clinical project, CAN10, has come into the spotlight. CAN10 has great potential for the treatment of various inflammatory diseases, and new results from our own and competitors' studies reinforce this view. Additionally, our other... (continue reading...)
LUND, SE / ACCESSWIRE / May 21, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its interim report for the first quarter of 2024.
"The year has started very well for Cantargia and our clinical project, CAN10, has come into the spotlight. CAN10 has great potential for the treatment of various inflammatory diseases, and new results from our own and competitors' studies reinforce this view. Additionally, our other... (continue reading...)
LUND, SE / ACCESSWIRE / May 21, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its interim report for the first quarter of 2024.
"The year has started very well for Cantargia and our clinical project, CAN10, has come into the spotlight. CAN10 has great potential for the treatment of various inflammatory diseases, and new results from our own and competitors' studies reinforce this view. Additionally, our other... (continue reading...)
LUND, SE / ACCESSWIRE / May 21, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its interim report for the first quarter of 2024.
"The year has started very well for Cantargia and our clinical project, CAN10, has come into the spotlight. CAN10 has great potential for the treatment of various inflammatory diseases, and new results from our own and competitors' studies reinforce this view. Additionally, our other... (continue reading...)
More Accesswire
View Older Stories-
Cantargia Publishes Interim Report for the First Quarter of 2024
-
Cantargia Publishes Interim Report for the First Quarter of 2024
-
Cantargia Publishes Interim Report for the First Quarter of 2024
-
Cantargia Publishes Interim Report for the First Quarter of 2024
-
Cantargia Publishes Interim Report for the First Quarter of 2024
-
Cantargia Publishes Interim Report for the First Quarter of 2024
-
IRLAB Presents at ABGSC Investor Days
-
IRLAB Presents at ABGSC Investor Days
-
IRLAB Presents at ABGSC Investor Days
-
IRLAB Presents at ABGSC Investor Days
-
IRLAB Presents at ABGSC Investor Days
-
IRLAB Presents at ABGSC Investor Days
-
IRLAB Presents at ABGSC Investor Days
-
IRLAB Presents at ABGSC Investor Days
-
IRLAB Presents at ABGSC Investor Days
-
IRLAB Presents at ABGSC Investor Days
-
IRLAB Presents at ABGSC Investor Days
-
Teradyne Marks 8,000th J750 Semiconductor Test System Shipment
-
Allied Universal Announces Early Results of Its Cash Tender Offer for Its 6.625% Senior Secured Notes Due 2026
-
Liberty Business Loans Help Small Businesses Innovate
-
Bemidji Mechatronics Training
-
Charlie’s Holdings Reports First Quarter 2024 Results
-
ConMet Unveils Latest Freight Efficiency Technologies at ACT Expo 2024
-
APWG Q1 Report: Phone-Based Phishing Grows Explosively, Shifting the Cybercrime Threatscape
-
The India Fund, Inc. Announces Distribution Payment Details
-
Meta Materials Announces Update on Naked Short Selling Investigation
-
Lakeland Industries Appoints James M. Jenkins as New President and CEO
-
Study Finds Electrifying NioCorp's Critical Minerals Mine Could Lead to Faster Time to Full Production Plus Significant Economic and Environmental Gains
-
Logitech Honored With 10 Design Award Wins From Red Dot for 2024
-
CompassMSP Announces an Exciting New Brand Design and Customer Web Experience, Plus Enhanced Cybersecurity and Compliance Services, to Add to Its Powerful Managed Services
-
Coastal Vision Medical Group Pioneers SMILE Pro With the VisuMax(R) 800
-
Integrated Approach to Sustainability Yields Progress on ESG Goals
-
Clarity Benefit Solutions Earns APEX Award for Exceptional Achievement at 2024 Alegeus Partner Success Summit
-
GoDaddy 2023 Sustainability Report: About GoDaddy | Corporate Governance
-
Cornerstone Foodservice Group Broadens Equipment Portfolio With Acquisition of Equipex
-
$Bobe Rebrands Its Platform by Modifying Old Logo to New Logo
-
Dow, Henkel and Kraton Jointly Drive Sustainability in North American Consumer Goods Industry
-
CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call
-
Fast Pace Health Recognizes Mental Health Awareness Month and Expands Access to Care
-
EquityMultiple Raises Alpine Note Rates Amid Continued Investor Enthusiasm
-
Ecora Resources PLC Announces Transaction in Own Shares
-
CannaPharmaRx to Host Investor Conference Call
-
Emergency Care Partners Recognized as One of the Best Places to Work in Healthcare 2024
-
International Paper Publishes 2023 Sustainability Report
-
GrowthZone Acquires JUNO to Enhance Member Engagement Capabilities
-
Center Point Bio-Tech Signs National Distribution Agreement
-
Founding Fathers Coffee Increases Commitment of Giving Back With Dollar General Expansion
-
Covia Honored With the 2024 Environmental/Sustainability Award
-
OLB Group Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Prehost.com Unveils Web Hosting Speed Insights From 17M+ Websites
